PML Colocalizes with and Stabilizes the DNA Damage Response Protein TopBP1

REFERENCES

• Alcalay, M., L. Thomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Gagioli, L. Szekely, K. Helin, and P. G. Pellicci. 1998. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. 18: 1084–1093.
   PubMedGoogle Scholar
• Bischof, O., S. H. Kim, J. Irving, S. Beresten, N. A. Ellis, and J. Campisi. 2001. Regulation and localization of the Bloom syndrome protein in response to DNA damage. J. Cell Biol. 153: 367–380.
   PubMed Web of Science ®Google Scholar
• Boisvert, F.-M., M. J. Kruhlak, A. K. Box, M. J. Hendzel, and D. P. Bazett-Jones. 2001. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152: 1099–1106.
   PubMedGoogle Scholar
• Carbone, R., M. Pearson, S. Minucci, and P. P. Pelicci. 2002. PML NBs associate with hMre11 complex and p53at sites of irradiation-induced DNA damage. Oncogene 21: 1633–1640.
   PubMed Web of Science ®Google Scholar
• Coultas, L., and A. Strasser. 2000. The molecular control of DNA damage-induced cell death. Apoptosis 5: 491–507.
   PubMed Web of Science ®Google Scholar
• Doucas, V., M. Tini, D. A. Egan, and R. M. Evans. 1999. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA 96: 2627–2632.
   PubMedGoogle Scholar
• Ellis, N. A., and J. German. 1996. Molecular genetics of Bloom's syndrome. Hum. Mol. Genet. 5: 1457–1463.
   PubMedGoogle Scholar
• Ferbeyre, G., E. Stanchina, E. Querido, N. Baptiste, C. Prives, and S. W. Lowe. 2000. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14: 2015–2027.
   PubMed Web of Science ®Google Scholar
• Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P. P. Pandolfi, H. Will, C. Schneider, and G. Del Sal. 2000. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19: 6185–6195.
   PubMed Web of Science ®Google Scholar
• Grobelny, J. V., A. K. Godwin, and D. Broccoli. 2000. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J. Cell Sci. 113: 4577–4585.
   PubMedGoogle Scholar
• Guo, A., P. Salomoni, J. Luo, A. Shih, S. Zhong, W. Gu, and P. P. Pandolfi. 2000. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2: 730–736.
   PubMed Web of Science ®Google Scholar
• He, D., Z. M. Mu, X. F. Le, J.-T. Hsieh, R.-C. Pong, L. W. K. Chung, and K. S. Chang. 1997. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res. 57: 1868–1872.
   PubMed Web of Science ®Google Scholar
• Honda, Y., M. Tojo, K. Matsuzaki, T. Anan, M. Matsumoto, M. Ando, H. Saya, and M. Nakao. 2002. Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response. J. Biol. Chem. 277: 3599–3605.
   PubMed Web of Science ®Google Scholar
• Ishov, A. M., A. G. Sotnikov, D. Negorev, O. V. Vladimirova, N. Neff, T. Kamitani, E. T. Yeh, J. F. Strauss II, and G. G. Maul. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147: 221–234.
   PubMed Web of Science ®Google Scholar
• Kamitani, T., K. Kito, H. P. Nyuyen, H. Wada, T. Fukuda-Kamitani, and E. T. Yeh. 1998. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273: 26675–26682.
   PubMedGoogle Scholar
• Khan, M. M., T. Nomura, H. Kim, S. C. Kaul, R. Wadhwa, T. Shinagawa, E. Ichikawa-Iwata, S. Zhong, P. P. Pandolfi, and S. Ishii. 2001. Role of PML and PML-RAR in Mad-mediated transcriptional repression. Mol. Cell 7: 1233–1243.
   PubMedGoogle Scholar
• Khanna, K. K., and S. P. Jackson. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27: 247–254.
   PubMed Web of Science ®Google Scholar
• Labachev, K. S., D. A. Gordenin, and M. A. Resnick. 2002. The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements. Cell 108: 183–193.
   PubMedGoogle Scholar
• LaMorte, V. J., J. A. Dyck, R. L. Ochs, and R. M. Evans. 1998. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95: 4991–4996.
   PubMedGoogle Scholar
• Lanotte, M., V. Martin-Thouvenin, S. Najman, P. Ballerini, F. Valensi, and R. Berger. 1991. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080–1086.
   PubMed Web of Science ®Google Scholar
• Le, X. F., S. Vallian, Z. M. Mu, M. C. Hung, and K. S. Chang. 1998. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16: 1839–1849.
   PubMedGoogle Scholar
• Lehembre, F., S. Muller, P. P. Pandolfi, and A. Dejean. 2001. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene 20: 1–9.
   PubMedGoogle Scholar
• Li, H., C. Leo, J. Zhu, X. Y. Wu, J. O'Neil, E. J. Park, and J. D. Chen. 2000. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20: 1784–1796.
   PubMed Web of Science ®Google Scholar
• Lin, R. J., T. Sternsdorf, M. Tini, and R. M. Evans. 2001. Transcriptional regulation in acute promyelocytic leukemia. Oncogene 20: 7204–7215.
   PubMed Web of Science ®Google Scholar
• Makiniemi, M. T., J. Hillukkala, K. Reini, M. Vaara, D. Huang, H. Pospiech, I. Majuri, T. Westerling, T. P. Makela, and J. E. Syvaoja. 2001. BRCT domain-containing protein TopBP1 functions in DNA replication and damage response. J. Biol. Chem. 276: 30399–30406.
   PubMed Web of Science ®Google Scholar
• Melnick, J., and D. Licht. 1999. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167–3215.
   PubMed Web of Science ®Google Scholar
• Mirzoeva, O. K., and J. H. J. Petrini. 2001. DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol. Cell. Biol. 21: 281–288.
   PubMed Web of Science ®Google Scholar
• Modesti, M., and R. Kanaar. 2001. DNA repair: spot(light)s on chromatin. Curr. Biol. 11: R229–232.
   PubMed Web of Science ®Google Scholar
• Moynahan, M. E., J. W. Chiu, B. H. Koller, and M. Jasin. 1999. Brca1 controls homology-directed DNA repair. Mol. Cell 4: 511–518.
   PubMed Web of Science ®Google Scholar
• Mu, Z. M., X. F. Le, S. Vallian, A. B. Glassman, and K. S. Chang. 1997. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18: 2063–2069.
   PubMedGoogle Scholar
• Mu, Z. M., K. V. Chin, J. H. Liu, G. Lozano, and K. S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14: 6858–6867.
   PubMed Web of Science ®Google Scholar
• Muratani, M. D., Gerlich, S. M. Janicki, M. Gebhard, R. Eils, and D. L. Spector. 2002. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat. Cell Biol. 4: 106–110.
   PubMedGoogle Scholar
• Pandita, T. K. 2002. ATM function and telomere stability. Oncogene 21: 611–618.
   PubMed Web of Science ®Google Scholar
• Pearson, M., R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y. Higashimoto, E. Appella, S. Minucci, P. P. Pandolfi, and P. G. Pelicci. 2000. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207–210.
   PubMed Web of Science ®Google Scholar
• Pearson, M., and P. G. Pelicci. 2001. PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20: 7250–7256.
   PubMedGoogle Scholar
• Petrini, J. H. J., R. S. Maser, and D. A. Bressan. 2001. The MRE11-RAD50 complex. DNA Damage Repair 3: 147–172.
   Google Scholar
• Quignon, F., F. De Bels, M. Koken, J. Feunteun, J. C. Ameisen, and H. de The. 1998. PML induces a novel caspase-independent death process. Nat. Genet. 20: 259–265.
   PubMedGoogle Scholar
• Raderschall, E., E. I. Golub, and T. Haaf. 1999. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc. Natl. Acad. Sci. USA 96: 1921–1926.
   PubMed Web of Science ®Google Scholar
• Rouse, J., and S. P. Jackson. 2002. Interfaces between the detection, signaling, and repair of DNA damage. Science 297: 547–551.
   PubMed Web of Science ®Google Scholar
• Saka, Y., F. Esashi, T. Matsusaka, S. Mochida, and M. Yanagida. 1997. Damage and replication checkpoint control in fission yeast is ensured by interactions of Crb2, a protein with BRCT motif, with cut5 and Chk1. Genes Dev. 11: 3387–3400.
   PubMedGoogle Scholar
• Saka, Y., P. Fantes, T. Sutani, C. McInerny, J. Creanor, and M. Yanagida. 1994. Fission yeast cut5 links nuclear chromatin and M phase regulator in the replication checkpoint control. EMBO J. 13: 5319–5329.
   PubMedGoogle Scholar
• Seeler, J.-S., and A. Dejean. 2001. SUMO: of branched proteins and nuclear bodies. Oncogene 20: 7243–7249.
   PubMed Web of Science ®Google Scholar
• Stadler, M., M. K. Chelbi-Alix, M. H. M. Koken, L. Venturini, C. Lee, A. Saib, F. Quignon, L. Pelicano, M. C. Guillemin, C. Schindler, and H. de The. 1995. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11: 2565–2573.
   PubMed Web of Science ®Google Scholar
• Thompson, L. H., and D. Schild. 2001. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res. 477: 131–153.
   PubMed Web of Science ®Google Scholar
• Vallian, S., J. A. Gaken, I. D. Trayner, E. B. Gingold, T. Kourizarides, K. S. Chang, and F. Farzaneh. 1997. Transcriptional repression by the promyelocytic leukemia protein. Exp. Cell Res. 237: 371–382.
   PubMedGoogle Scholar
• Vallian, S., A. J. Gaken, E. B. Gingold, T. Kouzarides, K. S. Chang, and F. Farzaneh. 1998. Regulation of Fos-mediated AP1 transcription by the promyelocytic leukemia protein. Oncogene 16: 2843–2853.
   PubMedGoogle Scholar
• Vallian, S., K. V. Chin, and K. S. Chang. 1998. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol. Cell. Biol. 18: 5147–5156.
   Google Scholar
• Venkitaraman, A. R. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171–182.
   PubMed Web of Science ®Google Scholar
• Wang, Z. G., D. Ruggero, S. Ronchetti, S. Zhong, M. Gaboli, R. Rivi, and P. P. Pandolfi. 1998. PML is essential for multiple apoptotic pathways. Nat. Genet. 20: 266–272.
   PubMed Web of Science ®Google Scholar
• Watts, P. M., and I. D. Hickson. 1996. Failure to unwind causes cancer, genome stability Curr. Biol. 6: 265–267.
   Google Scholar
• Wu, W. S., S. Vallian, E. Seto, W. M. Yang, D. Edmondson, S. Roth, and K. S. Chang. 2001. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol. Cell. Biol. 21: 2259–2268.
   PubMed Web of Science ®Google Scholar
• Wu, W. S., Z. X. Xu, and K. S. Chang. 2002. The promyelocytic leukemia protein represses A20-mediated transcription. J. Biol. Chem. 277: 31734–31739.
   PubMedGoogle Scholar
• Wu, W. S., Z. X. Xu, R. Ran, F. Meng, and K. S. Chang. 2002. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene 21: 3925–3933.
   PubMedGoogle Scholar
• Yamane, K., and T. Tsuruo. 1999. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Oncogene 18: 5194–5203.
   PubMedGoogle Scholar
• Yamane, K., X. Wu, and J. Chen. 2002. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Mol. Cell. Biol. 22: 555–566.
   PubMed Web of Science ®Google Scholar
• Yeager, T. R., A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble, and R. R. Reddel. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59: 4175–4179.
   PubMed Web of Science ®Google Scholar
• Zhong, Q., T. G. Boyer, L. P. Chen, and W.-H. Lee. 2002. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res. 62: 3966–3970.
   PubMed Web of Science ®Google Scholar
• Zhong, S., T. Z. Ye, R. Stan, N. A. Ellis, and P. P. Pandolfi. 1999. A role for PML and the nuclear body in genomic stability. Oncogene 18: 7841–7847.
   Google Scholar
• Zhong, S., P. Solomoni, and P. P. Pandolfi. 2000. The transcriptional role of PML and the nuclear body. Nat. Cell. Biol. 2: E85–E90.
   PubMed Web of Science ®Google Scholar
• Zhong, S., S. Muller, S. Ronchetti, P. S. Freemont, A. Dejean, and P. P. Pandolfi. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748–2752.
   PubMed Web of Science ®Google Scholar